Keywords: Pfizer, China, Japan, Generics,
Pfizer to be biggest beneficiary of China pharma market, say Goldman Sachs analysts; firm also set for Japanese generics market
Article | 24 November 2009
The world’s largest drugmaker, USA-based Pfizer, is eyeing the Japanese generics market and, in an investment review of the ...
Enjoying this article? To continue reading you need to login or subscribe.